News, reviews and podcasts from annual scientific meetings and symposiums around the world.
Parents of children newly diagnosed with cancer value the results of whole exome sequencing for…
A phase III trial of sunitinib has met its primary endpoint of disease-free survival for…
Although randomised clinical trials (RCTs) remain the gold standard for evaluating the benefit/risk of cancer…
This year marked the 25th anniversary of the Australasian Gastro-Intestinal Trials Group (AGITG) conducting and…
The PARP inhibitor niraparib significantly improves the outcome of platinum-sensitive recurrent ovarian cancer, according to…
Financial difficulties can significantly impact a cancer patient’s quality of life during treatment and may…
Neoadjuvant chemotherapy with an anthracycline plus ifosfamide was associated with significant survival gains in patients…
Men who received hormonal therapy for prostate cancer had a net harm if they had…
In a recent study, a Yale Cancer Center team revealed that the addition of chemotherapy…
A database study examining surgical removal of the prostate gland (radical prostatectomy) or a form…